ZHER2:4107
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ZHER2:4107, covering 2025-12-18 to 2025-12-18. Get the full timeline:
Most recent: Clinical Trial Update: Evaluation of Different Types of HER2 Expression in Breast Cancer Using [99mTc]Tc -ZHER2:4107 [Phase 2]